| Name | Goldenrod Manor |
|---|---|
| Location | 225 West Laperla Drive, Clarinda, Iowa |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 45 |
| Occupancy Rate | 70% |
| Medicare ID (CCN) | 165489 |
| Legal Business Name | Jp Senior Healthcare Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1891790150 |
| Organization Name | JP SENIOR HEALTHCARE LLC |
| Doing Business As | GOLDENROD MANOR CARE CENTER |
| Address | 225 W Laperla Dr, Clarinda, IA 51632 |
| Phone Number | 712-542-5621 |
News Archive
The American Pain Foundation today announced the launch of PainSAFE (Pain Safety & Access For Everyone), a new educational initiative designed for people with pain and health care professionals. The mission of PainSAFE is to provide education surrounding the appropriate and safe use of pain management therapies for people affected by pain and health care professionals, thereby, helping to reduce risk and improve access to quality pain care.
Doctors and hospitals nationwide expect a surge in H1N1 influenza cases during the upcoming flu season. In a new video and the tips below, Yvonne Maldonado, MD, chief of infectious disease at Lucile Packard Children's Hospital at Stanford, explains what every parent should know about H1N1 flu as children head back to school.
In the Center for Global Development's "Global Health Policy" blog, Amanda Glassman, director of global health policy at CGD, and Kate McQueston, program coordinator at the center, examine spending on tuberculosis, including drugs to fight susceptible and multidrug-resistant strains of the bacteria.
AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.
Researchers at Washington University School of Medicine in St. Louis have shown that a controversial phenomenon known as antibody-dependent enhancement (ADE) of infection is suppressed by C1q, a blood-borne immune system compound.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The American Pain Foundation today announced the launch of PainSAFE (Pain Safety & Access For Everyone), a new educational initiative designed for people with pain and health care professionals. The mission of PainSAFE is to provide education surrounding the appropriate and safe use of pain management therapies for people affected by pain and health care professionals, thereby, helping to reduce risk and improve access to quality pain care.
Doctors and hospitals nationwide expect a surge in H1N1 influenza cases during the upcoming flu season. In a new video and the tips below, Yvonne Maldonado, MD, chief of infectious disease at Lucile Packard Children's Hospital at Stanford, explains what every parent should know about H1N1 flu as children head back to school.
In the Center for Global Development's "Global Health Policy" blog, Amanda Glassman, director of global health policy at CGD, and Kate McQueston, program coordinator at the center, examine spending on tuberculosis, including drugs to fight susceptible and multidrug-resistant strains of the bacteria.
AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.
Researchers at Washington University School of Medicine in St. Louis have shown that a controversial phenomenon known as antibody-dependent enhancement (ADE) of infection is suppressed by C1q, a blood-borne immune system compound.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 7.56 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.48 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 38.46 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.74 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 9.6 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.75 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.3 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.85 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 63.89 | 83.88 |